Philip F. Palmedo
2022
In 2022, Philip F. Palmedo earned a total compensation of $84.5K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 81% decrease compared to previous year.
Compensation breakdown
| Option Awards | $63,340 |
|---|---|
| Other | $21,148 |
| Total | $84,488 |
Palmedo received $63.3K in option awards, accounting for 75% of the total pay in 2022.
Palmedo also received $21.1K in other compensation.
Rankings
In 2022, Philip F. Palmedo's compensation ranked 5,565th out of 5,690 executives tracked by ExecPay. In other words, Palmedo earned more than 2.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,565 out of 5,690 | 2nd |
Division Manufacturing | 3,033 out of 3,095 | 2nd |
Major group Chemicals And Allied Products | 1,382 out of 1,406 | 2nd |
Industry group Drugs | 1,289 out of 1,307 | 1st |
Industry Pharmaceutical Preparations | 934 out of 949 | 2nd |
Source: SEC filing on November 4, 2024.
Palmedo's colleagues
We found six more compensation records of executives who worked with Philip F. Palmedo at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
Bas der Baan
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
René Bernards
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Yun Yen
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Regina Brown
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Stephen Forman
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Gil Schwartzberg
LIXTE BIOTECHNOLOGY HOLDINGS